Muellerian-Inhibiting Factor clinical trials
8 active trials name this biomarker in their eligibility criteria. Describe your situation to see which ones you may be eligible for.
- In Vitro Maturation of Human Eggs
- IVM With Low Cost Priming, Enhanced Oocyte Recovery, and Delayed Transfer
- Human Menopausal Gonadotropin Research in Infertility Assessing Cumulative Live Birth With Frozen Embryo Transfer.
- Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV
- Ovarian PRP Injections for Improved Embryo Quality Using Embryo Quality Score
- Combined Oral Contraceptive Pill and Resistance Starch
- The REgistry of Very Early Estrogen and AnovuLation
- Use of Pulsatile Intravenous FSH to Mitigate Reprometabolic Syndrome
Guides for people searching for a trial
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that name “Muellerian-Inhibiting Factor” in their eligibility criteria, at any level. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.